Epstein-Barr virus infects and induces apoptosis in human neutrophils

Blood

Volumn 92, Issue 1, 1998, Pages 291-299

  Larochelle, Bernard ^b   Flamand, Louis ^b   Gourde, Pierrette ^b   Beauchamp, Denis ^b   Gosselin, Jean ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; ELECTRON MICROSCOPY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTIOUS MONONUCLEOSIS; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ADSORPTION; VIRUS INFECTION;

EID: 0032125752     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.291.413k34_291_299     Document Type: Article

References (50)

1. McColl SR, Showell HJ: Neutrophil-derived inflammatory mediators, in Williams TJ, Helliwell PC (eds): Immunopharmacology of the Neutrophil, vol 4. London, UK, Academic, 1994, p 95
2. Lioyd AR, Oppenheim JJ: Poly's lament: The neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 13:169, 1992
3. Meltzer MS, Skillman DR, Hoover DL, Hanson BD, Turpin JA, Kalter DC, Gendelman HE: Macrophages and the human immunodeficiency virus. Immunol Today 11:217, 1990
4. Turtinen LW, Saltzman R, Jordan MC, Haase AT: Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog 3:287, 1987
5. Daigneault DE, Hartshorn KL, Liou LS, Abbruzzi GM, White MR, Oh SK, Tauber AI: Influenza A virus binding to human neutrophils and cross-linking requirements for activation. Blood 80:3227, 1992
6. Rothwell SW, Wright DG: Characterization of influenza A virus binding sites on human neutrophils. J Immunol 152:2358, 1994
7. Hartshorn KL, Karnad AB, Tauber AI: Influenza A virus and the neutrophil: a model of natural immunity. J Leukoc Biol 47:176, 1990
8. Tsoukas CD, Lambris JD: Expression of EBV-C3d receptors on T cells: Biological significance. Immunol Today 14:56, 1993
9. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD: Infection of human thymocytes by Epstein-Barr virus. J Exp Med 173:971, 1991
10. Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD: Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2. J Immunol 22:1123, 1992
11. Sinha SK, Todd SC, Hedrick JA, Speiser CL, Lambris JD, Tsoukas CD: Characterization of the EBV/C3d receptor on the human Jurkat T cell line: Evidence for a novel transcript. J Immunol 150:5311, 1993
12. Paterson RL, Kelleher C, Amankonah TD, Streib JE, Xu JW, Jones JF, Gelfand EW: Model of Epstein-Barr virus infection of human thymocytes: Expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood 85:456, 1995
13. Menezes J, Seigneurin JM, Patel P, Bourkas A, Lenoir G: Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4). J Virol 22:816, 1977
14. Sauvageau G, Stocco R, Kasparian S, Menezes J: Epstein-Barr virus receptor expression in human CD8+ (cytotoxic/suppressor) T lymphocytes. J Gen Virol 71:371, 1990
15. Gosselin J, Menezes J, D'Addario M, Hiscott J, Flamand L, Lamoureux G, Oth D: Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus. Eur J Immunol 21:203, 1991
16. Hedrick JA, Lao Z, Lipps SG, Wang Y, Todd SC, Lambris JD, Tsoukas CD: Characterization of a 70-kDa, EBV gp350/220-binding protein on HSB-2 T cells. J Immunol 153:4418, 1994
17. Beaulieu AD, Paquin R, Gosselin J: Epstein-Barr virus modulates de novo protein synthesis in human neutrophils. Blood 86:2789, 1995
18. Roberge CJ, Poubelle PE, Beaulieu AD, Heitz D, Gosselin J: The IL-1 and IL-1 receptor antagonist (IL-1Ra) response of human neutrophils to EBV stimulation. Preponderance of IL-1Ra detection. J Immunol 156:4884, 1996
19. Layne SP, Merges MJ, Dembo M, Spouge JL, Conley SR, Moore JP, Raina JL, Renz H, Gelderblom HR, Nara PL: Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695, 1992
20. Hayat MA: Basic techniques for transmission electron microscopy. Orlando, FL, Academic, 1986
21. Jeanpierre M: A rapid method for the purification of DNA from blood. Nucleic Acids Res 15:9611, 1987
22. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG: DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207, 1984
23. Pouliot M, McDonald PP, Krump E, Mancini JA, McColl SR, Weech PK, Borgeat P: Colocalization of cytosolic phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur J Biochem 238:250, 1996
24. Tierney RJ, Steven N, Young LS, Rickinson AB: Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374, 1994
25. Lipman ML, Stevens C, Bleackley C, Helderman JH, McCune TR, Harmon WE, Shapiro ME, Rosen S, Strom TB: The strong correlation of cytotoxic T lymphocyte-specific serin protease gene transcripts with renal allograft rejection. Transplantation 53:79, 1992
26. Pollack A, Ciancio G: Cell cycle phase-specific analysis of cell viability using Hoechst 33342 and propidium iodide after ethanol preservation, in Darzynkiewicz Z, Crissman HA (eds): Flow Cytometry, vol 33. San Diego, CA, Academic, 1991, p 19
27. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795, 1992
28. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB: Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612, 1991
29. Kawanishi M: Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection. J Virol 67:7654, 1993
30. Brach MA, deVos S, Gruss HJ, Herrmann F: Prolongation of survival of human polymorphonuclear neutrophils by granulocytemacrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920, 1992
31. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429, 1996
32. Alfieri C, Birkenbach M, Kieff E: Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595, 1991
33. Hammerschmidt W, Sugden B: Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340:393, 1989
34. Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E: Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 64:3407, 1990
35. Countryman J, Miller G: Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 82:4085, 1985
36. Kelleher CA, Paterson RK, Dreyfus DH, Streib JE, Xu JW, Takase K, Jones JF, Gelfand EW: Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its represser RAZ. Virology 208:685, 1995
37. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM: Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361:739, 1993
38. Fesq H, Bacher M, Nain M, Gemsa D: Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobioiogy 190:175, 1994
39. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R: Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol 74:2347, 1993
40. Hinshaw VS, Olsen CW, Dybdahl Sissoko N, Evans D: Apoptosis: A mechanism of cell killing by influenza A and B viruses. J Virol 68:3667, 1994
41. Henderson S, Rowe M, Gregory C, Croom Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107, 1991
42. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961, 1991
43. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA, Delia Porta G: bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291, 1992
44. Wulff HR: Acute agranulocytosis following infectious mononucleosis. Report of a case. Scand J Haematol 2:179, 1965
45. Habib MA, Babka JC, Bumingham RA: Profound granulocytopenia associated with infectious mononucleosis. Am J Med Sci 265:339, 1973
46. Neel EU: Infectious mononucleosis. Death due to agranulocytosis and pneumonia. JAMA 236:1493, 1976
47. Eriksson KF, Holmberg L, Bergstrand CG: Infectious mononucleosis and agranulocytosis. Scand J Infect Dis 11:307, 1979
48. Hammond WP, Harlan JM, Steinberg SE: Severe neutropenia in infectious mononucleosis. West J Med 131:92, 1979
49. Schooley RT, Densen P, Harmon D, Felsenstein D, Hirsch MS, Henle W, Weitzman S: Antineutrophil antibodies in infectious mononucleosis. Am J Med 76:85, 1984
50. Stevens DL, Everett ED, Boxer LA, Landefeld RA: Infectious mononucleosis with severe neutropenia and opsonic antineutrophil activity. South Med J 72:519, 1979